RapidArc Radiotherapy Technology Enabling Fast, Accurate Treatments for Pennsylvania Cancer Patients
Posted on: Wednesday, 22 April 2009, 07:00 CDT
Prostate and brain cancer patients were the first in the area to benefit
"The prostate cancer patient's tumor was close to the bladder, rectum, and many other sensitive organs and tissues," said
For the patient with the brain tumor, Dr. Andrews was able to deliver a RapidArc treatment designed to minimize exposure of her eyes, pituitary gland, and other sensitive organs and tissues in the head and neck.
For both patients, the RapidArc treatments were much faster than would have been possible using earlier generations of technology. "With RapidArc, prostate cancer treatments that once took ten minutes to deliver can now be completed in just two minutes," Dr. Andrews said. "The typical set-up and treatment time for a brain cancer patient used to be about 40 minutes, but with RapidArc, we're completing these treatments in just over ten minutes."
As a result, cancer patients spend much less time immobilized on the treatment table. In addition to improving patient comfort, faster treatments help reduce the chance of tumor motion during treatment. According to Dr. Andrews, for a prostate cancer patient, as the bladder fills, the tumor can move by several millimeters. "The RapidArc treatments are delivered so quickly that there really isn't enough time for the tumor to move," said Dr. Andrews.
Hospitals and cancer centers from around the world have now used RapidArc radiotherapy technology for the treatment of prostate, head and neck, lung, brain, spine, bone, gynecological, and soft tissue cancers. The American Cancer Society's most recent estimates show that in 2008 there were 70,110 new cancer cases in the state of
About
Lehigh Valley Health Network includes three hospital facilities - two in
About Varian Medical Systems
Varian Medical Systems, Inc., of
SOURCE Varian Medical Systems, Inc.
Source: PR Newswire
Related Articles
- Examine the Phase III Clinical Data Recently Released About ACAPODENE in the Treatment of Prostate Cancer
- New Studies Unveiled at ASTRO's 49th Annual Meeting of Radiation Oncology Specialists Support the Effectiveness of IsoRay Medical's Proxcelan(TM) for the Treatment of Prostate Cancer
- Curecumin(TM) May Be an Effective Treatment for Prostate Cancer
- InterCommunity Cancer Center in Leesburg Introduces IsoRay Medical, Inc.'s Cesium-131 Medical Isotope for Treating Prostate Cancer; First Implant in Florida Using Breakthrough Treatment Scheduled for Today (Wednesday, April 26)
- Cancer Drug May Double As an Arthritis Treatment
- Breakthrough May Improve Treatment of Prostate Cancer
- Community Care Physicians of Latham, New York Deliver Ultra-Precise Image-Guided Radiotherapy Treatments for Prostate Cancer Patients
- New Study Confirms Value of Vitamin D Supplementation in the Adjunctive Treatment of Prostate Cancer
- New Targeted Treatment for Prostate Cancer Available in Chicago
- Prostate Cancer and the Principles of Hormone Therapy Treatment
User Comments (0)

RSS Feeds